Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Pond

Showing results (31-40 of 255) with videos related to

Pageof 26
Sort By:
Journal of the National Cancer Institute|April 12, 2012
Assumptions of expected benefits in randomized phase III trials evaluating systemic treatments for cancerHui K Gan, Benoit You, Gregory R Pond, et al.
BMC Cancer|January 6, 2021
A population-based analysis of spirometry use and the prevalence of chronic obstructive pulmonary disease in lung cancerSophie Corriveau, Gregory R Pond, Grace H Tang, et al.
Plos One|May 17, 2021
Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare systemJohn R Goffin, Sophie Corriveau, Grace H Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Radiation therapy for Bowen's disease of the skinLauren A Lukas VanderSpek, Gregory R Pond, Woodrow Wells, et al.
BMJ Oncology|January 31, 2025
Pharmacological class effects of anticancer drugs: opportunities for decreasing healthcare spendingDaniel A Goldstein, Leonard B Saltz, Gregory R Pond, et al.
American Journal of Clinical Oncology|October 9, 2007
The influence of mentorship on research productivity in oncologyRachel P Riechelmann, Carol A Townsley, Gregory R Pond, et al.
Clinical Trials (London, England)|April 22, 2010
Trends in the application of dynamic allocation methods in multi-arm cancer clinical trialsGregory R Pond, Patricia A Tang, Stephen A Welch, et al.
Immunotherapy|June 13, 2025
Time toxicity of nivolumab in metastatic head and neck squamous cell carcinoma patients: a single-institution experienceMichelle Bradbury, Adam Gabara, Gregory R Pond, et al.
JCO Oncology Practice|July 25, 2024
Patterns of Survivorship Follow-Up Care Among Patients With Breast Cancer: A Retrospective Population-Based Cohort Study in Ontario, Canada, Between 2006 and 2016Jonathan Sussman, Joshua O Cerasuolo, Gregory R Pond, et al.
Clinical Biochemistry|April 15, 2014
Assessing the necessity of including a crossover period with dual reporting when changing total prostate-specific antigen methodsAngela C Rutledge, Gregory R Pond, Sebastien J Hotte, et al.
Pageof 26

Showing results (31-40 of 255) with videos related to

Sort By:
Pageof 26
Journal of the National Cancer Institute|April 12, 2012
Assumptions of expected benefits in randomized phase III trials evaluating systemic treatments for cancerHui K Gan, Benoit You, Gregory R Pond, et al.
BMC Cancer|January 6, 2021
A population-based analysis of spirometry use and the prevalence of chronic obstructive pulmonary disease in lung cancerSophie Corriveau, Gregory R Pond, Grace H Tang, et al.
Plos One|May 17, 2021
Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare systemJohn R Goffin, Sophie Corriveau, Grace H Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Radiation therapy for Bowen's disease of the skinLauren A Lukas VanderSpek, Gregory R Pond, Woodrow Wells, et al.
BMJ Oncology|January 31, 2025
Pharmacological class effects of anticancer drugs: opportunities for decreasing healthcare spendingDaniel A Goldstein, Leonard B Saltz, Gregory R Pond, et al.
American Journal of Clinical Oncology|October 9, 2007
The influence of mentorship on research productivity in oncologyRachel P Riechelmann, Carol A Townsley, Gregory R Pond, et al.
Clinical Trials (London, England)|April 22, 2010
Trends in the application of dynamic allocation methods in multi-arm cancer clinical trialsGregory R Pond, Patricia A Tang, Stephen A Welch, et al.
Immunotherapy|June 13, 2025
Time toxicity of nivolumab in metastatic head and neck squamous cell carcinoma patients: a single-institution experienceMichelle Bradbury, Adam Gabara, Gregory R Pond, et al.
JCO Oncology Practice|July 25, 2024
Patterns of Survivorship Follow-Up Care Among Patients With Breast Cancer: A Retrospective Population-Based Cohort Study in Ontario, Canada, Between 2006 and 2016Jonathan Sussman, Joshua O Cerasuolo, Gregory R Pond, et al.
Clinical Biochemistry|April 15, 2014
Assessing the necessity of including a crossover period with dual reporting when changing total prostate-specific antigen methodsAngela C Rutledge, Gregory R Pond, Sebastien J Hotte, et al.
Pageof 26